English
factory Outlets for Eflornithine Hydrochloride Monohydrate - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu Featured Image
  • factory Outlets for Eflornithine Hydrochloride Monohydrate - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu

factory Outlets for Eflornithine Hydrochloride Monohydrate - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

The corporate upholds the philosophy of "Be No.1 in excellent, be rooted on credit rating and trustworthiness for growth", will keep on to serve outdated and new clients from home and abroad whole-heatedly for Darunavir CAS 206361-99-1, Dicyclohexylcarbodiimide, Molecular Formula C21H21N3O5, We believe you will be satisfied with our reasonable price, high quality products and fast delivery. We sincerely hope you can give us an opportunity to serve you and be your best partner!
factory Outlets for Eflornithine Hydrochloride Monohydrate - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu Detail:

Manufacturer Commercial Supply Remdesivir and Related Intermediates with High Quality

Chemical Name Molnupiravir (EIDD-2801)
Synonyms MK-4482; β-D-N4-Hydroxycytidine-5′-isopropyl ester; ((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
CAS Number 2349386-89-4, 2492423-29-5
CAT Number RF-API97
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C13H19N3O7
Molecular Weight 329.31
Solubility Soluble in DMSO
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-White Powder
Identification IR Sample Spectrum corresponds to that of reference standard
Identification HPLC The retention time of the major peak of the sample solution corresponds to that of the standard solution
Related Substances
20H01 ≤0.10%
20H02 ≤0.10%
20H04 ≤0.10%
20HIb ≤0.10%
20H21 ≤0.10%
Any Unspecified Impurity ≤0.10%
Total Unspecified Impurities ≤0.30%
Total Impurities ≤0.50%
Residual Solvents
N-Heptane ≤5000ppm
Ethanol ≤5000ppm
Isopropyl Acetate ≤5000ppm
Acetonitrile ≤410ppm
Methylene Dichloride ≤600ppm
Acetone ≤5000ppm
Isopropanol ≤5000ppm
Water Content (K.F) ≤0.50%
Loss on Drying ≤1.0%
Residue on Ignition ≤0.10%
Optical Rotation -7.5° to -9.5° (C=0.5, Methanol)
Heavy Metals ≤10ppm
Purity / Analysis Method ≥99.5% (230nm)
Assay / Analysis Method 98.0%~102.0% (HPLC on dried basis)
Shelf Life 24 Months
Test Standard Enterprise Standard
Usage API, Molnupiravir (EIDD-2801) COVID-19 Inhibitor

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1

Molnupiravir (EIDD-2801, MK-4482) is an orally bioavailable prodrug of the ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) with broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and the causative agent of COVID-19. Molnupiravir is sold under the brand name Lagevrio and generically as emorivir. Molnupiravir has been shown to improve pulmonary function, decrease body weight loss and reduce the amount of virus in the lung. In addition to activity against coronaviruses, Molnupiravir, in laboratory studies, has demonstrated activity against seasonal and bird influenza, respiratory syncytial virus, chikungunya virus, Ebola virus, Venezuelan equine encephalitis virus, and Eastern equine encephalitis virus. Molnupiravir was originally developed to treat influenza at Emory University by the university’s drug innovation company, Drug Innovation Ventures at Emory (DRIVE), but was reportedly abandoned for mutagenicity concerns. It was then acquired by Miami-based company Ridgeback Biotherapeutics, which later partnered with Merck & Co. to develop the drug further. Molnupiravir was approved for medical use in the United Kingdom in November 2021.

Product detail pictures:

factory Outlets for Eflornithine Hydrochloride Monohydrate - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu detail pictures

Related Product Guide:
We insist over the principle of enhancement of 'High high quality, Efficiency, Sincerity and Down-to-earth working approach' to offer you with superb assistance of processing for factory Outlets for Eflornithine Hydrochloride Monohydrate - Molnupiravir (EIDD-2801) CAS 2349386-89-4 COVID-19 API High Quality – Ruifu , The product will supply to all over the world, such as: Curacao, Guyana, Juventus, Our company absorbs new ideas, strict quality control, a full range of service tracking, and adhere to make high-quality products. Our business aims to "honest and trustworthy, favorable price, customer first", so we won the trust of the majority of customers! If you are interested in our products and services, please do not hesitate to contact us!
    • Although we are a small company, we are also respected. Reliable quality, sincere service and good credit, we are honored to be able to work with you!
    5 Stars By jari dedenroth from Sevilla - 2017.11.29 11:09
    It is really lucky to meet such a good supplier, this is our most satisfied cooperation, I think we will work again!
    5 Stars By Hilary from Macedonia - 2018.06.03 10:17
    Write your message here and send it to us